Skip to main content
. 2020 May 12;32(5):332–341. doi: 10.1093/intqhc/mzaa039

Table 3.

Cost data

Item Costs (GBP) QALY
Ileocolonoscopy, per procedure 654.18a 0.0025
PVCE, per procedure 800.75a,d 0.0014
MRE, per procedure 206.51a
CTE, per procedure 120.07a
Faecal calprotectin test, per procedure 123.33a,e
Clinical assessment of symptoms, per procedure 108e
Infliximab, per year 5278 (NICE TA187) 0.00032
Infliximab, administration cost 225
Adalimumab, per year 2860 (NICE TA187) 0.00052
Adalimumab, administration costs 0
Vedolizumab, per year 24 350 (NICE TA352) 0.00032
Vedolizumab, administration costs 310 (NICE TA352)
Corticosteroids, per year 90 (NICE CG152)
Corticosteroids, administration costs 0
Azathioprine, per year 4 (methotrexate used)
Azathioprine, administration costs 0
Inflixmab + azathioprine, per year 5282 0.00032
Infliximab + azathioprine, administration costs 225
Remission 10 0.8 [49]
Non-active symptomatic 30 0.61 [49]
Active symptomatic 50 0.5 [49]
Active non-symptomatic 20 0.8 [49]
Surgery 16 583 [1] 0.022 [50]
Abscess drainage 2569a
Fistula repair 2951a
Stricturing repair 2951a
Capsule retention b 645a 0.0025c [51]
Bowel perforation 8797a 0.010 [52]

CTE, computed tomography enterography; MRE, magnetic resonance enterography; PVCE, pan-intestinal video capsule endoscopy

a

Reference Cost Collection: National Schedule of Reference Costs, 2016–17—NHS trusts and NHS foundation trusts

b

5% of capsule retentions are treated as required for surgery.

c

Removal via push-endoscopy.

d

Costs include GBP 758.75 for the PVCE procedure and GBP 42 for the patency capsule.

e

Costs including follow-up attendance with a single gastroenterologist (code 301, NHS England National Prices and Tariffs Workbook 2016/17).